Motor Neurone Disease Queensland
supporting people living with MND,
their families and carers.  

Today the Queensland Government put a number of Council areas into a 3-day lockdown.  This includes Brisbane City where our office is located.  If you are unaware of the restrictions that may apply to you from 6pm today Friday 8 January to 6pm on Monday 11 January then please access the Queensland Health site on https://www.qld.gov.au/health/conditions/health-alerts/coronavirus-covid-19.

CHAMPION MND/ALS STUDY

 

The CHAMPION MND/ALS Study is a Phase III, double-blind, randomised, placebo-controlled, parallel-group, multicentre study with an open-label extension period, to evaluate the efficacy and safety of ravulizumab in adult patients with amyotrophic lateral sclerosis (ALS or Motor Neurone Disease/MND). Ravulizumab is an investigational medication not currently approved for use in patients with MND/ALS in any country worldwide.